EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Long-Term Survival of LVAD Patients—A TriNetX Database Analysis

Nandini Nair iD, Balakrishnan Mahesh, Dongping Du iD

Journal of Clinical Medicine · 13.07.2024 · 13 (14) · 4096

DOI: 10.3390/jcm13144096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.07.2024. Verfasst von Nandini Nair und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology, Penn State Health/PSUCOM, 500 University Drive, Hershey, PA 17033, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Donor shortage limits the utilization of heart transplantation, making it available for only a fraction of the patients on the transplant waiting list. Therefore, continuous-flow left ventricular assist devices (CF-LVADs) have evolved as a standard of care for end-stage heart failure. It is imperative therefore to investigate long-term survival in this population.

Methods

This study assesses the impact of demographics, infections, comorbidities, types of cardiomyopathies, arrhythmias, and end-organ dysfunction on the long-term survival of LVAD recipients. The TriNetX database comprises de-identified patient information across healthcare organizations. The log-rank test assessed post-implant survival effects, while Cox regression was used in the univariate analysis to obtain the Hazard Ratio (HR). All analyses were conducted using the Python programming language and the lifelines library.

Results

This study identified CMV, hepatitis A exposure, atrial fibrillation, paroxysmal ventricular tachycardia, ischemic cardiomyopathy, renal dysfunction, diabetes, COPD, mitral valve disease, and essential hypertension as risk factors that impact long-term survival. Interestingly, hypokalemia seems to have a protective effect and gender does not affect survival significantly.

Conclusions

This is the first report of a detailed long-term survival assessment of the LVAD population using a decoded database.

Schlagwörter

Stichwörter der Autor:innen

LVAD long-term survivalTriNetXrisk factors

Autor:innen und Institutionen

  • Department of Medicine, Division of Cardiology, Penn State Health/PSUCOM, 500 University Drive, Hershey, PA 17033, USA.
  • Department of Surgery, Division of Cardiothoracic Surgery, Penn State Health/PSUCOM, 500 University Drive, Hershey, PA 17033, USA.
  • Department of Industrial, Manufacturing and Systems Engineering, Texas Tech University (TTU), Lubbock, TX 79409, USA.

ORCID-Profile: Nandini Nair, Dongping Du

Förderung

  • NCATS NIH HHS

Zitieren

APA

Nair, N., Mahesh, B., & Du, D. (2024). The Long-Term Survival of LVAD Patients—A TriNetX Database Analysis. Journal of Clinical Medicine, 13(14), 4096. https://doi.org/10.3390/jcm13144096

Vancouver

Nair N, Mahesh B, Du D. The Long-Term Survival of LVAD Patients—A TriNetX Database Analysis. Journal of Clinical Medicine. 2024;13(14):4096. doi:10.3390/jcm13144096

BibTeX
@article{Nair2024,
  author = {Nair, Nandini and Mahesh, Balakrishnan and Du, Dongping},
  title = {The Long-Term Survival of LVAD Patients—A TriNetX Database Analysis},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {14},
  pages = {4096},
  doi = {10.3390/jcm13144096}
}
Kostenlos starten →